Your indoor versus outdoor environment could have an even bigger impact on your eczema symptoms than you realize.

Comorbid chronic inflammatory diseases influence the prognosis of alopecia areata, according to study findings.

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...

Therapeutics, Inc. (NASDAQ:APGE), has sold 15,000 shares of the company's common stock, according to a recent SEC filing. The biotech company, currently valued at $2.37 billion, has received a ...

Officer of Apogee (NASDAQ:APOG) Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biopharmaceutical company with a market capitalization of $2.4 billion, recently sold shares of the company's common ...

About Stapokibart About Stapokibart Stapokibart is a high-efficient, humanized antibody targeting the interleukin-4 receptor alpha subunit (IL-4Rα), and is the first domestically manufactured IL-4Rα ...

Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused ...

According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...